# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-041992
Filing Date
2025-03-19
Accepted
2025-03-19 16:08:15
Documents
19
Period of Report
2025-03-19

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | atyr-20250319.htm iXBRL | DEF 14A | 1510887
2 | GRAPHIC | img41052685_0.jpg | GRAPHIC | 7986
3 | GRAPHIC | img41052685_1.jpg | GRAPHIC | 53811
4 | GRAPHIC | img41052685_2.jpg | GRAPHIC | 57291
5 | GRAPHIC | img41052685_3.jpg | GRAPHIC | 7986
6 | GRAPHIC | img41052685_4.jpg | GRAPHIC | 1369509
7 | GRAPHIC | img41052685_5.jpg | GRAPHIC | 425925
| Complete submission text file | 0000950170-25-041992.txt |  | 6452402

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | atyr-20250319.xsd | EX-101.SCH | 7935
21 | EXTRACTED XBRL INSTANCE DOCUMENT | atyr-20250319_htm.xml | XML | 123302

Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

EIN.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37378 | Film No.: 25752747
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)